PIM-35
PIM-35[edit | edit source]
PIM-35 is a chemical compound that belongs to the class of phosphoinositide 3-kinase (PI3K) inhibitors. It is primarily studied for its potential therapeutic applications in the treatment of various cancers and inflammatory diseases. PIM-35 is known for its ability to selectively inhibit specific isoforms of PI3K, which are enzymes involved in cellular functions such as growth, proliferation, and survival.
Mechanism of Action[edit | edit source]
PIM-35 functions by targeting the PI3K signaling pathway, which is crucial for many cellular processes. The PI3K pathway is activated by various growth factors and cytokines, leading to the production of phosphatidylinositol (3,4,5)-trisphosphate (PIP3). PIP3 acts as a second messenger, activating downstream signaling proteins such as AKT and mTOR, which promote cell survival and growth.
By inhibiting PI3K, PIM-35 reduces the levels of PIP3, thereby decreasing the activation of AKT and mTOR. This results in the induction of apoptosis (programmed cell death) and inhibition of cell proliferation, making PIM-35 a promising candidate for cancer therapy.
Applications in Cancer Therapy[edit | edit source]
The PI3K pathway is often dysregulated in cancer, leading to uncontrolled cell growth and survival. PIM-35 has shown potential in preclinical studies for the treatment of various types of cancer, including breast cancer, lung cancer, and leukemia. Its ability to selectively inhibit specific PI3K isoforms allows for targeted therapy, potentially reducing side effects associated with non-selective PI3K inhibitors.
Research and Development[edit | edit source]
Research on PIM-35 is ongoing, with studies focusing on its efficacy, safety, and pharmacokinetics. Clinical trials are being conducted to evaluate its potential as a monotherapy or in combination with other anticancer agents. The development of PIM-35 is part of a broader effort to create targeted therapies that can improve outcomes for patients with cancer and other diseases involving the PI3K pathway.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
